CSI Market
Sign In | Register

Spyre Therapeutics Inc (SYRE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SYRE Annual Balance Sheets →
Quarterly balance sheet trends provide context on Spyre Therapeutics Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent1,100.00
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments1,100.00
Prepaid Expense And Other Assets Current27.66
Total Current Assets1,173.00
Other Assets, Noncurrent45.35
Total Assets1,173.00
Liabilities
Accounts Payable, Current AC0.00
Accrued Liabilities And Other Liabilities0.00
Derivative Liability, Current DE38.62
Other Liabilities, Current0.00
Total Current Liabilities63.30
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE7.27
Other liabilities, Noncurrent25.97
Total Liabilities71.86
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock2,189.94
Retained Earnings / Accumulated Deficit-1,232.84
Accumulated Other Comprehensive Income-2.40
Other Equity-2.40
Common Stockholder's Equity1,101.14
Preferred Stockholder's Equity0.00
Total Stockholder's Equity1,101.14
Liabilities & Stockholder's Equity1,173.00
4 historic quarters locked

Sign in to unlock the full Spyre Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Spyre Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001636282-26-000096

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.